Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its neuroprotection for the PC12 cells damaged by lactacystin

Neuroscience Bulletin

Volumn 23, Issue 2, 2007, Pages 67-74

  Su, Ya Ru ^a   Wang, Jian ^a   Wu, Jian Jun ^a   Chen, Yan ^a   Jiang, Yu Ping ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Bone marrow stromal cells; Gene therapy; Glial cell line derived neurotrophic factor; Lentivirus; Parkinson's disease; Proteasome inhibitor

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LACTACYSTIN; LENTIVIRUS VECTOR; LIPOFECTAMINE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL STRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; IMMUNOCYTOCHEMISTRY; LENTIVIRINAE; MALE; NEUROPROTECTION; NONHUMAN; PLASMID; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; VIRAL GENE DELIVERY SYSTEM;

ACETYLCYSTEINE; ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DNA, RECOMBINANT; GENE THERAPY; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; LENTIVIRUS; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; PLASMIDS; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STROMAL CELLS; TRANSDUCTION, GENETIC;

EID: 34249054529     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-007-0010-5     Document Type: Article

References (26)

1. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260: 1130-1132.
2. Costa S, Iravani MM, Pearce RK, Jenner P. Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets. Eur J Pharmacol 2001, 412: 45-50.
3. Bowenkamp KE, Lapchak PA, Hoffer BJ, Miller PJ, Bickford PC. Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats. Exp Neurol 1997, 145: 104-117.
4. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998, 72: 8463-8471.
5. Chen Q, Long Y, Yuan X, Zou L, Sun J, Chen S, et al. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J Neurosci Res 2005, 80: 611-619.
6. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998, 395: 451-452.
7. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392: 605-608.
8. McNaught KS, Jenner P. Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci Lett 2001, 297: 191-194.
9. Wu S, Suzuki Y, Ejiri Y, Noda T, Bai H, Kitada M, et al. Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. J Neurosci Res 2003, 72: 343-351.
10. Lou S, Gu P, Chen F, He C, Wang M, Lu C. The effect of bone marrow stromal cells on neuronal differentiation of mesencephalic neural stem cells in Sprague-Dawley rats. Brain Res 2003, 968: 114-121.
11. Ye M, Chensheng D, Qi C, Guoqiang L, Liang L, Xujie Y. Expression of mRNAs and prote in for glial cell line2der ived neurotrophic factors in bone marrow stromal cells of SD rat. Neurosci Bull 2005, 21: 23-27.
12. Park KW, Eglitis MA, Mouradian MM. Protection of nigral neurons by GDNF-engineered marrow cell transplantation. Neurosci Res 2001, 40: 315-323.
13. Elkon H, Melamed E, Offen D. Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. J Mol Neurosci 2004, 24: 387-400.
14. Moser SS, Besler-Panos W. Pharmacotherapy for Parkinson's disease: current options, promising future therapies. JAAPA 2006, 19: 38-44.
15. Wirth T, Yla-Herttuala S. Gene technology based therapies in the brain. Adv Tech Stand Neurosurg 2006, 31: 3-32.
16. Limberis MP, Wilson JM. Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc Natl Acad Sci USA 2006, 103: 12993-12998.
17. Bankiewicz KS, Forsayeth J, Eberling JL, Sanchez-Pernaute R, Pivirotto P, Bringas J, et al. Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAVhAADC. Mol Ther 2006, 14: 564-570.
18. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998, 72: 9873-9880.
19. Kang UJ, Fisher LJ, Joh TH, O'Malley KL, Gage FH. Regulation of dopamine production by genetically modified primary fibroblasts. J Neurosci 1993, 13: 5203-5211.
20. Dass B, Olanow CW, Kordower JH. Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease. Neurology 2006, 66 (10 Suppl 4): S89-S103.
21. Lu J, Moochhala S, Moore XL, Ng KC, Tan MH, Lee LK, et al. Adult bone marrow cells differentiate into neural phenotypes and improve functional recovery in rats following traumatic brain injury. Neurosci Lett 2006, 398: 12-17.
22. Garcia R, Aguiar J, Alberti E, de la Cuetara K, Pavon N. Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochem Biophys Res Commun 2004, 316: 753-754.
23. Qiu JH, Asai A, Chi S, Saito N, Hamada H, Kirino T. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J Neurosci 2000, 20: 259-265.
24. Hyun DH, Lee M, Halliwell B, Jenner P. Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J Neurochem 2003, 86: 363-373.
25. Lev N, Melamed E, Offen D. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage. Neurosci Lett 2006, 399: 27-32.
26. Omura S, Fujimoto T, Otoguro K, Matsuzaki K, Moriguchi R, Tanaka H, et al. Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J Antibiot 1991, 44: 113-116.